+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The failure of growth hormone to modify hormonal hypertension in the rat

The failure of growth hormone to modify hormonal hypertension in the rat

Canadian Journal of Biochemistry and Physiology 32(3): 200-205

Growth hormone (Connaught) was given in 1 mg. daily doses to rats either otherwise untreated or given sufficient DCA or Compound F to elicit a moderate hypertensive response. At the dose level used, growth hormone did not affect either blood pressure or kidney size in treated or untreated animals. The dose used was a 5th the amt. found to increase renal function in the dog and 10 times the dose required for trophic effects in the rat.

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 025789104

Download citation: RISBibTeXText

PMID: 13150243

Related references

Failure of amantadine to modify serum growth hormone and insulin levels. Experientia 29(5): 573, 1973

Chronic renal failure and human growth hormone treatment do not modify endothelium-dependent reactions in the rat aorta in vitro. Journal Of Autonomic Pharmacology. 16(2): 97-103, 1996

Short-term recombinant human growth hormone therapy does not modify growth hormone, thyrotropin and prolactin responses to thyrotropin-releasing hormone in adult dialysis patients. Nephrology, Dialysis, Transplantation 15(6): 856-861, 2000

Failure of growth hormone therapy in a girl with growth hormone deficiency and steroid-induced growth failure caused by prednisolone administration. Dokkyo Journal of Medical Sciences 30(1): 93-96, 2003

Failure to demonstrate anti-hormonal antibodies in rats after maximal response to daily administration of growth hormone. Proc Soc Exptl Biol And Med 105(1): 102-103, 1960

Growth hormone response to a bolus injection of 1-44 growth-hormone-releasing hormone in very short children with intrauterine onset of growth failure. Hormone Research 33(5): 161-165, 1990

Diurnal administration of human growth hormone-releasing factor does not modify sleep and sleep-related growth hormone secretion in normal young men. Acta Endocrinologica 110(2): 158-163, 1985

Failure of neomycin to modify ACTH induced hypertension in sheep. Clinical and Experimental Pharmacology and Physiology 11(6): 645-647, 1984

Failure of repeated diazoxide injections to modify the course of severe hypertension. American Heart Journal 79(6): 742-751, 1970

Growth hormone addition for patients with congestive heart failure A randomized, placebo controlled study with recombinant human growth hormone in patients with congestive heart failure and without growth hormone deficiency. Journal of the American College of Cardiology 31(2 Suppl. A): 249A, 1998

Failure of calcitonin to modify prolactin and thyroid stimulating hormone secretion. Hormone & Metabolic Research 12(4): 174-175, 1980

Failure to respond to growth hormone releasing hormone in acromegaly due to a growth hormone releasing hormone secreting pancreatic tumor dynamics of multiple endocrine testing. Journal of Clinical Endocrinology & Metabolism 61(3): 585-587, 1985

Resting metabolic rate, body composition and related hormonal parameters in growth hormone-deficient adults before and after growth hormone replacement therapy. European Journal of Endocrinology 133(4): 445-450, 1995

Monoclonal antibodies to bovine growth hormone potentiate hormonal activity in vivo by enhancing growth hormone binding to hepatic somatogenic receptors. Journal of Endocrinology 139(3): 383-393, 1993

An immunocytochemical analysis of the hormonal status of animals transgenic for growth hormone genes and for a mini-gene of human growth hormone-releasing factor. Tsitologiia 36(4): 372-377, 1994